Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • April 2006 | Volume 19 - Issue 4
    By Anthony Leone, Special Projects Editor
    5,926 reads | 0 comments | 04/03/06
    When it comes to adjunctive modalities for the treatment of diabetic neuropathy, podiatrists may want to consider the supplement Metanx (Pamlab). Two podiatrists cite the modality as a safe and effective treatment option for those with diabetic neuropathy. Comprised of 2.8 mg of L-methylfolate, 25 mg of pyrioxal 5’-phosphate (B6) and 2 mg of methylcobalamin (B12), Metanx has been proven to increase nitric oxide (NO) synthesis and improve endothelial function, according to Allen Jacobs, DPM, and Theodore Varoz, DPM, PCPM, DFW. Dr. Jacobs notes that B6 facilitates neural regeneration and B12 ... continue reading
    Guest Clinical Editor: Bruce Williams, DPM
    8,457 reads | 0 comments | 04/03/06
    Although what one learned in podiatric medical school is invaluable in a podiatry career, sometimes podiatrists may encounter a different reality in clinical practice. These expert panelists weigh what they learned in school with their experience and the current research. They also detail which directions future orthotic research should take. Q: What is the current research telling us about how the foot really functions as opposed to what many podiatrists were taught in school? A: Much of the current research focuses on the importance of the midtarsal joint(s) and how they have a ... continue reading

    5,416 reads | 0 comments | 04/03/06
    For patients with dermatological conditions, a new product may be able to provide some relief. Ammonium Lactate Cream 12% is indicated for ichthyosis vulgaris and xerosis, according to the manufacturer, Paddock Laboratories. The product offers 12% lactic acid neutralized with ammonium hydroxide, according to the company. As Paddock Labs says, when one applies lactic acid to the skin, it may decrease corneocyte cohesion. In addition, the company says an in vitro study showed that in cadaver skin, 6.1 percent of the Ammonium Lactate Cream was absorbed in 68 hours. It is available in a lot ... continue reading
    By Patrick A. DeHeer, DPM
    18,928 reads | 0 comments | 04/03/06
    When a foot and ankle specialist is involved as part of the medical staff for a college or professional basketball team, the demands on injury prevention and rehabilitation are significant. This high level of specialized care in the professional and collegiate setting involves several people, including the players, coaches, trainer, other medical staff and management in professional teams. Since treatment can involve the careers of those associated with the team, there is a certain amount of pressure on the treating physician. With so much at stake, two critical factors play an integral ro ... continue reading
    By John H. McCord, DPM
    1,843 reads | 0 comments | 04/03/06
    I have never been much of a fan of American football. This is partly due to a trauma related to the game early in my life. My father took me to a University of Montana Grizzly game when I was 5 years old. Naturally, we sat in the cheap seats, rickety bleachers used mostly by impoverished students and my father. It was my first opportunity to watch a football game and I tried to concentrate but the tedium of timeouts, huddles and slow movement of huge men adorned in padding and helmets caused me to daydream. I dozed off, fell out of the bleachers and fractured my clavicle. I swore off football ... continue reading